Alphatec Spine to Showcase Comprehensive Product Portfolio at the Upcoming 28th Annual North American Spine Society (NASS) Me...
02 Oktober 2013 - 12:31AM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that provides
physician-inspired solutions for patients with spinal disorders,
announced today that it will showcase several new products at the
upcoming North American Spine Society (NASS) meeting in New
Orleans, LA, which will be held from October 9th – 12th, 2013.
Alphatec Spine will be located in booth number 631.
This year's product showcase will include:
ILLICO® Multi-Level (ML) Minimally Invasive Surgery
System (MIS) is Alphatec Spine's simple, secure and highly
versatile solution for minimally invasive posterior fixation for
addressing instability in the thoracic and lumbar spine. With the
ILLICO ML system surgeons are able to address complex multi-level
spinal trauma and deformities and therefore ensure reliable
reproducible results, which are designed to minimize pain and help
speed recovery for their patients. This system features the
minimally invasive ILLICO MIS Posterior Fixation System and the
ILLICO FS Facet Fixation screws.
Alphatec NEXoss™ Nanostructure BA Matrix is a
next-generation synthetic bone graft that provides the optimal
microenvironment to support reliable, consistent bone growth for
patients during the healing process. Alphatec NEXoss is comprised
of an innovative bioactive scaffold engineered to support
successful posterolateral fusions through two unique patented
technologies that work in tandem: a unique collagen biopolymer that
contributes to bone growth and nanostructure hydroxyapatite (HA)
crystals that mimic natural bone composition, structure and
size.
Pegasus™ Anchored Cervical Interbody System is
the Company's newest anchored, cervical interbody device that
provides surgeons with a simplified approach to ACDF procedures.
Pegasus provides the delivery of a spacer with an integrated
anchoring mechanism in a single-step, non-impaction implantation,
which is designed to reduce operative time. The controlled anchor
deployment provides surgeons confidence and simple intra-operative
and post-operative removal if needed.
Alphatec Solus™ Anterior Lumbar Interbody
Fusion Device is the latest innovative
solution designed to provide fast, easy and effective stabilization
for ALIF procedures using a single-step process thereby benefitting
both surgeons and patients. Alphatec Solus delivers four points of
fixation that are deployed simultaneously while providing
substantial space to insert bone graft to help promote rapid fusion
at the site, all of which are designed to increase fixation and
decrease operative time.
"With our focus on physician-inspired solutions we are very
excited to be able to join researchers, key thought leaders, and
physicians at the 28th annual NASS meeting this month to discuss
innovations in the field of spinal disorders and related conditions
that can help lead to promising new therapeutic options for
patients," said Les Cross, Chairman and CEO of Alphatec Spine. "We
look forward to demonstrating the unique value and benefits of our
broad portfolio of complementary products that help play a role in
enabling patients to regain their active lifestyles and live better
lives."
In addition, on Thursday, October 10th at 5:30 pm, Alphatec
Spine is hosting an educational symposium featuring renowned
thought leaders Dr. Antonio Castellvi, M.D., Dr. Boyle Cheng, PhD.
and Dr. Celeste Abjornson, PhD. These distinguished professionals
will be speaking about key topics in the prevention and treatment
of spinal injuries and related conditions, including minimally
invasive techniques for multi-level constructs with ILLICO, results
of a biomechanical study of the NOVEL® ALIF device with integrated
fixation and next-generation bone grafting solutions. The Company
will also offer interactive sawbones workshops at its booth during
exhibit hours.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec
Holdings, Inc., is a medical device company that designs, develops,
manufactures and markets physician-inspired products and solutions
for the treatment of spinal disorders associated with trauma,
congenital deformities, disease and degeneration. The Company's
mission is to combine innovative surgical solutions with
world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in
the U.S. and in over 50 countries internationally via a direct
sales force and independent distributors.
Additional information can be found at
www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no
assurance that actual results or business conditions will not
differ materially from those projected or suggested in such
forward-looking statements as a result of various factors.
Forward-looking statements include references to the Company's
belief that certain of its products offer competitive
functionalities in the marketplace. In addition, forward-looking
statements include the Company's ability to develop and
commercialize new products, including the products discussed in
this press release. The words "believe," "will," "should,"
"expect," "intend," "estimate" and "anticipate," variations of such
words and similar expressions identify forward-looking statements,
but their absence does not mean that a statement is not a
forward-looking statement. The important factors that could cause
actual operating results to differ significantly from those
expressed or implied by such forward-looking statements include,
but are not limited to; the uncertainty of success in developing or
acquiring and commercializing new products or product technologies;
acceptance of Alphatec Spine's products by the surgeon community,
including the products discussed in this press release; Alphatec
Spine's ability to develop and expand its U.S. and/or global
revenues; continuation of favorable third part payor reimbursement
for procedures performed using Alphatec Spine's products, including
the products discussed in this press release; unanticipated
expenses or liabilities or other adverse events affecting cash flow
or Alphatec Spine's ability to successfully control its costs or
achieve profitability; uncertainty of additional funding; Alphatec
Spine's ability to compete with other competing products and with
emerging new technologies; product liability exposure; patent
infringement claims and claims related to Alphatec Spine's
intellectual property. Please refer to the risks detailed from time
to time in Alphatec Spine's SEC reports, including its Annual
Report Form 10-K, as well as other filings on Form 10-Q and
periodic filings on Form 8-K. Alphatec Spine disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, unless required by law.
CONTACT: Investor/Media Contact:
Christine Zedelmayer
Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
czedelmayer@alphatecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024